Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Biosimilars/Follow-on-Biologics Market Growth 2022-2028

  • LP 4837982
  • 104 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Biosimilars/Follow-on-Biologics will have significant change from previous year. According to our (LP Information) latest study, the global Biosimilars/Follow-on-Biologics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Biosimilars/Follow-on-Biologics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Biosimilars/Follow-on-Biologics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biosimilars/Follow-on-Biologics market, reaching US$ million by the year 2028. As for the Europe Biosimilars/Follow-on-Biologics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Biosimilars/Follow-on-Biologics players cover Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, and LG Life Sciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilars/Follow-on-Biologics market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Human Growth Hormone

Erythropoietin

Monoclonal Antibodies

Insulin

Interferon

Granulocyte-Colony Stimulating Factor

Peptide

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Blood Disorders

Oncology Diseases

Chronic and Autoimmune Diseases

Growth Hormone Deficiencies

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Novartis

Synthon Pharmaceuticals

Teva Pharmaceutical Industries

LG Life Sciences

Celltrion

Biocon

Hospira

Merck Group

Biogen idec, Inc.

Genentech (Roche Group)

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Biosimilars/Follow-on-Biologics Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Biosimilars/Follow-on-Biologics by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Biosimilars/Follow-on-Biologics by Country/Region, 2017, 2022 & 2028

2.2 Biosimilars/Follow-on-Biologics Segment by Type

2.2.1 Human Growth Hormone

2.2.2 Erythropoietin

2.2.3 Monoclonal Antibodies

2.2.4 Insulin

2.2.5 Interferon

2.2.6 Granulocyte-Colony Stimulating Factor

2.2.7 Peptide

2.2.8 Others

2.3 Biosimilars/Follow-on-Biologics Sales by Type

2.3.1 Global Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)

2.3.2 Global Biosimilars/Follow-on-Biologics Revenue and Market Share by Type (2017-2022)

2.3.3 Global Biosimilars/Follow-on-Biologics Sale Price by Type (2017-2022)

2.4 Biosimilars/Follow-on-Biologics Segment by Application

2.4.1 Blood Disorders

2.4.2 Oncology Diseases

2.4.3 Chronic and Autoimmune Diseases

2.4.4 Growth Hormone Deficiencies

2.4.5 Others

2.5 Biosimilars/Follow-on-Biologics Sales by Application

2.5.1 Global Biosimilars/Follow-on-Biologics Sale Market Share by Application (2017-2022)

2.5.2 Global Biosimilars/Follow-on-Biologics Revenue and Market Share by Application (2017-2022)

2.5.3 Global Biosimilars/Follow-on-Biologics Sale Price by Application (2017-2022)

3 Global Biosimilars/Follow-on-Biologics by Company

3.1 Global Biosimilars/Follow-on-Biologics Breakdown Data by Company

3.1.1 Global Biosimilars/Follow-on-Biologics Annual Sales by Company (2020-2022)

3.1.2 Global Biosimilars/Follow-on-Biologics Sales Market Share by Company (2020-2022)

3.2 Global Biosimilars/Follow-on-Biologics Annual Revenue by Company (2020-2022)

3.2.1 Global Biosimilars/Follow-on-Biologics Revenue by Company (2020-2022)

3.2.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company (2020-2022)

3.3 Global Biosimilars/Follow-on-Biologics Sale Price by Company

3.4 Key Manufacturers Biosimilars/Follow-on-Biologics Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Biosimilars/Follow-on-Biologics Product Location Distribution

3.4.2 Players Biosimilars/Follow-on-Biologics Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Biosimilars/Follow-on-Biologics by Geographic Region

4.1 World Historic Biosimilars/Follow-on-Biologics Market Size by Geographic Region (2017-2022)

4.1.1 Global Biosimilars/Follow-on-Biologics Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Biosimilars/Follow-on-Biologics Annual Revenue by Geographic Region

4.2 World Historic Biosimilars/Follow-on-Biologics Market Size by Country/Region (2017-2022)

4.2.1 Global Biosimilars/Follow-on-Biologics Annual Sales by Country/Region (2017-2022)

4.2.2 Global Biosimilars/Follow-on-Biologics Annual Revenue by Country/Region

4.3 Americas Biosimilars/Follow-on-Biologics Sales Growth

4.4 APAC Biosimilars/Follow-on-Biologics Sales Growth

4.5 Europe Biosimilars/Follow-on-Biologics Sales Growth

4.6 Middle East & Africa Biosimilars/Follow-on-Biologics Sales Growth

5 Americas

5.1 Americas Biosimilars/Follow-on-Biologics Sales by Country

5.1.1 Americas Biosimilars/Follow-on-Biologics Sales by Country (2017-2022)

5.1.2 Americas Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022)

5.2 Americas Biosimilars/Follow-on-Biologics Sales by Type

5.3 Americas Biosimilars/Follow-on-Biologics Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Biosimilars/Follow-on-Biologics Sales by Region

6.1.1 APAC Biosimilars/Follow-on-Biologics Sales by Region (2017-2022)

6.1.2 APAC Biosimilars/Follow-on-Biologics Revenue by Region (2017-2022)

6.2 APAC Biosimilars/Follow-on-Biologics Sales by Type

6.3 APAC Biosimilars/Follow-on-Biologics Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Biosimilars/Follow-on-Biologics by Country

7.1.1 Europe Biosimilars/Follow-on-Biologics Sales by Country (2017-2022)

7.1.2 Europe Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022)

7.2 Europe Biosimilars/Follow-on-Biologics Sales by Type

7.3 Europe Biosimilars/Follow-on-Biologics Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Biosimilars/Follow-on-Biologics by Country

8.1.1 Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Country (2017-2022)

8.1.2 Middle East & Africa Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022)

8.2 Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Type

8.3 Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Biosimilars/Follow-on-Biologics

10.3 Manufacturing Process Analysis of Biosimilars/Follow-on-Biologics

10.4 Industry Chain Structure of Biosimilars/Follow-on-Biologics

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Biosimilars/Follow-on-Biologics Distributors

11.3 Biosimilars/Follow-on-Biologics Customer

12 World Forecast Review for Biosimilars/Follow-on-Biologics by Geographic Region

12.1 Global Biosimilars/Follow-on-Biologics Market Size Forecast by Region

12.1.1 Global Biosimilars/Follow-on-Biologics Forecast by Region (2023-2028)

12.1.2 Global Biosimilars/Follow-on-Biologics Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Biosimilars/Follow-on-Biologics Forecast by Type

12.7 Global Biosimilars/Follow-on-Biologics Forecast by Application

13 Key Players Analysis

13.1 Novartis

13.1.1 Novartis Company Information

13.1.2 Novartis Biosimilars/Follow-on-Biologics Product Offered

13.1.3 Novartis Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis Main Business Overview

13.1.5 Novartis Latest Developments

13.2 Synthon Pharmaceuticals

13.2.1 Synthon Pharmaceuticals Company Information

13.2.2 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product Offered

13.2.3 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Synthon Pharmaceuticals Main Business Overview

13.2.5 Synthon Pharmaceuticals Latest Developments

13.3 Teva Pharmaceutical Industries

13.3.1 Teva Pharmaceutical Industries Company Information

13.3.2 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product Offered

13.3.3 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Teva Pharmaceutical Industries Main Business Overview

13.3.5 Teva Pharmaceutical Industries Latest Developments

13.4 LG Life Sciences

13.4.1 LG Life Sciences Company Information

13.4.2 LG Life Sciences Biosimilars/Follow-on-Biologics Product Offered

13.4.3 LG Life Sciences Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 LG Life Sciences Main Business Overview

13.4.5 LG Life Sciences Latest Developments

13.5 Celltrion

13.5.1 Celltrion Company Information

13.5.2 Celltrion Biosimilars/Follow-on-Biologics Product Offered

13.5.3 Celltrion Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Celltrion Main Business Overview

13.5.5 Celltrion Latest Developments

13.6 Biocon

13.6.1 Biocon Company Information

13.6.2 Biocon Biosimilars/Follow-on-Biologics Product Offered

13.6.3 Biocon Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Biocon Main Business Overview

13.6.5 Biocon Latest Developments

13.7 Hospira

13.7.1 Hospira Company Information

13.7.2 Hospira Biosimilars/Follow-on-Biologics Product Offered

13.7.3 Hospira Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Hospira Main Business Overview

13.7.5 Hospira Latest Developments

13.8 Merck Group

13.8.1 Merck Group Company Information

13.8.2 Merck Group Biosimilars/Follow-on-Biologics Product Offered

13.8.3 Merck Group Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Merck Group Main Business Overview

13.8.5 Merck Group Latest Developments

13.9 Biogen idec, Inc.

13.9.1 Biogen idec, Inc. Company Information

13.9.2 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Product Offered

13.9.3 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Biogen idec, Inc. Main Business Overview

13.9.5 Biogen idec, Inc. Latest Developments

13.10 Genentech (Roche Group)

13.10.1 Genentech (Roche Group) Company Information

13.10.2 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Product Offered

13.10.3 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Genentech (Roche Group) Main Business Overview

13.10.5 Genentech (Roche Group) Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Biosimilars/Follow-on-Biologics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Biosimilars/Follow-on-Biologics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Human Growth Hormone

Table 4. Major Players of Erythropoietin

Table 5. Major Players of Monoclonal Antibodies

Table 6. Major Players of Insulin

Table 7. Major Players of Interferon

Table 8. Major Players of Granulocyte-Colony Stimulating Factor

Table 9. Major Players of Peptide

Table 10. Major Players of Others

Table 11. Global Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)

Table 12. Global Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)

Table 13. Global Biosimilars/Follow-on-Biologics Revenue by Type (2017-2022) & ($ million)

Table 14. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Type (2017-2022)

Table 15. Global Biosimilars/Follow-on-Biologics Sale Price by Type (2017-2022) & (USD/Pcs)

Table 16. Global Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)

Table 17. Global Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)

Table 18. Global Biosimilars/Follow-on-Biologics Revenue by Application (2017-2022)

Table 19. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Application (2017-2022)

Table 20. Global Biosimilars/Follow-on-Biologics Sale Price by Application (2017-2022) & (USD/Pcs)

Table 21. Global Biosimilars/Follow-on-Biologics Sales by Company (2020-2022) & (K Pcs)

Table 22. Global Biosimilars/Follow-on-Biologics Sales Market Share by Company (2020-2022)

Table 23. Global Biosimilars/Follow-on-Biologics Revenue by Company (2020-2022) ($ Millions)

Table 24. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company (2020-2022)

Table 25. Global Biosimilars/Follow-on-Biologics Sale Price by Company (2020-2022) & (USD/Pcs)

Table 26. Key Manufacturers Biosimilars/Follow-on-Biologics Producing Area Distribution and Sales Area

Table 27. Players Biosimilars/Follow-on-Biologics Products Offered

Table 28. Biosimilars/Follow-on-Biologics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 29. New Products and Potential Entrants

Table 30. Mergers & Acquisitions, Expansion

Table 31. Global Biosimilars/Follow-on-Biologics Sales by Geographic Region (2017-2022) & (K Pcs)

Table 32. Global Biosimilars/Follow-on-Biologics Sales Market Share Geographic Region (2017-2022)

Table 33. Global Biosimilars/Follow-on-Biologics Revenue by Geographic Region (2017-2022) & ($ millions)

Table 34. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Geographic Region (2017-2022)

Table 35. Global Biosimilars/Follow-on-Biologics Sales by Country/Region (2017-2022) & (K Pcs)

Table 36. Global Biosimilars/Follow-on-Biologics Sales Market Share by Country/Region (2017-2022)

Table 37. Global Biosimilars/Follow-on-Biologics Revenue by Country/Region (2017-2022) & ($ millions)

Table 38. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Country/Region (2017-2022)

Table 39. Americas Biosimilars/Follow-on-Biologics Sales by Country (2017-2022) & (K Pcs)

Table 40. Americas Biosimilars/Follow-on-Biologics Sales Market Share by Country (2017-2022)

Table 41. Americas Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022) & ($ Millions)

Table 42. Americas Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2017-2022)

Table 43. Americas Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)

Table 44. Americas Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)

Table 45. Americas Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)

Table 46. Americas Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)

Table 47. APAC Biosimilars/Follow-on-Biologics Sales by Region (2017-2022) & (K Pcs)

Table 48. APAC Biosimilars/Follow-on-Biologics Sales Market Share by Region (2017-2022)

Table 49. APAC Biosimilars/Follow-on-Biologics Revenue by Region (2017-2022) & ($ Millions)

Table 50. APAC Biosimilars/Follow-on-Biologics Revenue Market Share by Region (2017-2022)

Table 51. APAC Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)

Table 52. APAC Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)

Table 53. APAC Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)

Table 54. APAC Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)

Table 55. Europe Biosimilars/Follow-on-Biologics Sales by Country (2017-2022) & (K Pcs)

Table 56. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Country (2017-2022)

Table 57. Europe Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022) & ($ Millions)

Table 58. Europe Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2017-2022)

Table 59. Europe Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)

Table 60. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)

Table 61. Europe Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)

Table 62. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)

Table 63. Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Country (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Country (2017-2022)

Table 65. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022) & ($ Millions)

Table 66. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2017-2022)

Table 67. Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)

Table 69. Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)

Table 70. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)

Table 71. Key Market Drivers & Growth Opportunities of Biosimilars/Follow-on-Biologics

Table 72. Key Market Challenges & Risks of Biosimilars/Follow-on-Biologics

Table 73. Key Industry Trends of Biosimilars/Follow-on-Biologics

Table 74. Biosimilars/Follow-on-Biologics Raw Material

Table 75. Key Suppliers of Raw Materials

Table 76. Biosimilars/Follow-on-Biologics Distributors List

Table 77. Biosimilars/Follow-on-Biologics Customer List

Table 78. Global Biosimilars/Follow-on-Biologics Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. Global Biosimilars/Follow-on-Biologics Sales Market Forecast by Region

Table 80. Global Biosimilars/Follow-on-Biologics Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Global Biosimilars/Follow-on-Biologics Revenue Market Share Forecast by Region (2023-2028)

Table 82. Americas Biosimilars/Follow-on-Biologics Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Americas Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. APAC Biosimilars/Follow-on-Biologics Sales Forecast by Region (2023-2028) & (K Pcs)

Table 85. APAC Biosimilars/Follow-on-Biologics Revenue Forecast by Region (2023-2028) & ($ millions)

Table 86. Europe Biosimilars/Follow-on-Biologics Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Europe Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Forecast by Country (2023-2028) & (K Pcs)

Table 89. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 90. Global Biosimilars/Follow-on-Biologics Sales Forecast by Type (2023-2028) & (K Pcs)

Table 91. Global Biosimilars/Follow-on-Biologics Sales Market Share Forecast by Type (2023-2028)

Table 92. Global Biosimilars/Follow-on-Biologics Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 93. Global Biosimilars/Follow-on-Biologics Revenue Market Share Forecast by Type (2023-2028)

Table 94. Global Biosimilars/Follow-on-Biologics Sales Forecast by Application (2023-2028) & (K Pcs)

Table 95. Global Biosimilars/Follow-on-Biologics Sales Market Share Forecast by Application (2023-2028)

Table 96. Global Biosimilars/Follow-on-Biologics Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 97. Global Biosimilars/Follow-on-Biologics Revenue Market Share Forecast by Application (2023-2028)

Table 98. Novartis Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors

Table 99. Novartis Biosimilars/Follow-on-Biologics Product Offered

Table 100. Novartis Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 101. Novartis Main Business

Table 102. Novartis Latest Developments

Table 103. Synthon Pharmaceuticals Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors

Table 104. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product Offered

Table 105. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 106. Synthon Pharmaceuticals Main Business

Table 107. Synthon Pharmaceuticals Latest Developments

Table 108. Teva Pharmaceutical Industries Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors

Table 109. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product Offered

Table 110. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 111. Teva Pharmaceutical Industries Main Business

Table 112. Teva Pharmaceutical Industries Latest Developments

Table 113. LG Life Sciences Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors

Table 114. LG Life Sciences Biosimilars/Follow-on-Biologics Product Offered

Table 115. LG Life Sciences Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 116. LG Life Sciences Main Business

Table 117. LG Life Sciences Latest Developments

Table 118. Celltrion Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors

Table 119. Celltrion Biosimilars/Follow-on-Biologics Product Offered

Table 120. Celltrion Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 121. Celltrion Main Business

Table 122. Celltrion Latest Developments

Table 123. Biocon Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors

Table 124. Biocon Biosimilars/Follow-on-Biologics Product Offered

Table 125. Biocon Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 126. Biocon Main Business

Table 127. Biocon Latest Developments

Table 128. Hospira Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors

Table 129. Hospira Biosimilars/Follow-on-Biologics Product Offered

Table 130. Hospira Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 131. Hospira Main Business

Table 132. Hospira Latest Developments

Table 133. Merck Group Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors

Table 134. Merck Group Biosimilars/Follow-on-Biologics Product Offered

Table 135. Merck Group Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 136. Merck Group Main Business

Table 137. Merck Group Latest Developments

Table 138. Biogen idec, Inc. Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors

Table 139. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Product Offered

Table 140. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 141. Biogen idec, Inc. Main Business

Table 142. Biogen idec, Inc. Latest Developments

Table 143. Genentech (Roche Group) Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors

Table 144. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Product Offered

Table 145. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 146. Genentech (Roche Group) Main Business

Table 147. Genentech (Roche Group) Latest Developments

List of Figures

Figure 1. Picture of Biosimilars/Follow-on-Biologics

Figure 2. Biosimilars/Follow-on-Biologics Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Biosimilars/Follow-on-Biologics Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Biosimilars/Follow-on-Biologics Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Biosimilars/Follow-on-Biologics Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Human Growth Hormone

Figure 10. Product Picture of Erythropoietin

Figure 11. Product Picture of Monoclonal Antibodies

Figure 12. Product Picture of Insulin

Figure 13. Product Picture of Interferon

Figure 14. Product Picture of Granulocyte-Colony Stimulating Factor

Figure 15. Product Picture of Peptide

Figure 16. Product Picture of Others

Figure 17. Global Biosimilars/Follow-on-Biologics Sales Market Share by Type in 2021

Figure 18. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Type (2017-2022)

Figure 19. Biosimilars/Follow-on-Biologics Consumed in Blood Disorders

Figure 20. Global Biosimilars/Follow-on-Biologics Market: Blood Disorders (2017-2022) & (K Pcs)

Figure 21. Biosimilars/Follow-on-Biologics Consumed in Oncology Diseases

Figure 22. Global Biosimilars/Follow-on-Biologics Market: Oncology Diseases (2017-2022) & (K Pcs)

Figure 23. Biosimilars/Follow-on-Biologics Consumed in Chronic and Autoimmune Diseases

Figure 24. Global Biosimilars/Follow-on-Biologics Market: Chronic and Autoimmune Diseases (2017-2022) & (K Pcs)

Figure 25. Biosimilars/Follow-on-Biologics Consumed in Growth Hormone Deficiencies

Figure 26. Global Biosimilars/Follow-on-Biologics Market: Growth Hormone Deficiencies (2017-2022) & (K Pcs)

Figure 27. Biosimilars/Follow-on-Biologics Consumed in Others

Figure 28. Global Biosimilars/Follow-on-Biologics Market: Others (2017-2022) & (K Pcs)

Figure 29. Global Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)

Figure 30. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Application in 2021

Figure 31. Biosimilars/Follow-on-Biologics Revenue Market by Company in 2021 ($ Million)

Figure 32. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company in 2021

Figure 33. Global Biosimilars/Follow-on-Biologics Sales Market Share by Geographic Region (2017-2022)

Figure 34. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Geographic Region in 2021

Figure 35. Global Biosimilars/Follow-on-Biologics Sales Market Share by Region (2017-2022)

Figure 36. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Country/Region in 2021

Figure 37. Americas Biosimilars/Follow-on-Biologics Sales 2017-2022 (K Pcs)

Figure 38. Americas Biosimilars/Follow-on-Biologics Revenue 2017-2022 ($ Millions)

Figure 39. APAC Biosimilars/Follow-on-Biologics Sales 2017-2022 (K Pcs)

Figure 40. APAC Biosimilars/Follow-on-Biologics Revenue 2017-2022 ($ Millions)

Figure 41. Europe Biosimilars/Follow-on-Biologics Sales 2017-2022 (K Pcs)

Figure 42. Europe Biosimilars/Follow-on-Biologics Revenue 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Biosimilars/Follow-on-Biologics Sales 2017-2022 (K Pcs)

Figure 44. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue 2017-2022 ($ Millions)

Figure 45. Americas Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2021

Figure 46. Americas Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2021

Figure 47. United States Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 48. Canada Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 49. Mexico Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 50. Brazil Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 51. APAC Biosimilars/Follow-on-Biologics Sales Market Share by Region in 2021

Figure 52. APAC Biosimilars/Follow-on-Biologics Revenue Market Share by Regions in 2021

Figure 53. China Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 54. Japan Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 55. South Korea Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 56. Southeast Asia Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 57. India Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 58. Australia Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 59. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2021

Figure 60. Europe Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2021

Figure 61. Germany Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 62. France Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 63. UK Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 64. Italy Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 65. Russia Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 66. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2021

Figure 67. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2021

Figure 68. Egypt Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 69. South Africa Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 70. Israel Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 71. Turkey Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 72. GCC Country Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 73. Manufacturing Cost Structure Analysis of Biosimilars/Follow-on-Biologics in 2021

Figure 74. Manufacturing Process Analysis of Biosimilars/Follow-on-Biologics

Figure 75. Industry Chain Structure of Biosimilars/Follow-on-Biologics

Figure 76. Channels of Distribution

Figure 77. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390